Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.

Cancer biology & therapy - 2 Aug 2020

Wang Tao, Liu Zhengsheng, Wang Xuegang, Bai Peide, Sun Anran, Shao Zhiqiang, Luo Rongtuan, Wu Zhun, Zhang Kaiyan, Li Wei, Xiao Wen, Duan Bo, Wang Yongfeng, Chen Bin, Xing Jinchun

Abstract excerpt

Patients with urothelial carcinoma (UC) of the bladder have a high risk of death in China. However, a lack of comprehensive molecular profiling in Chinese Han population hinders the development of targeted therapies for bladder cancer. In our present study, we collected fresh bladder tumors from low-grade (T1, N0, M0, G1) non-muscle invasive bladder cancer (NMIBC) patients (n = 16) and high-grade (T2-4, N0, M0,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32449441
DOI: 10.1080/15384047.2020.1763148
PMCID: PMC7515499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.PMID 32449441Read ↗

Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome SequencingSemantic proximity Read ↗

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapySemantic proximity Read ↗

Analysis of the Relationship between Bladder Cancer Gene Mutation and Clinical Prognosis by High-Throughput Sequencing.Semantic proximity Read ↗

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read ↗

Genomic Profiling of Chinese Urothelial Carcinoma PatientsSemantic proximity Read ↗

Frontiers in Bladder Cancer Genomic ResearchSemantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug InteractionsSemantic proximity Read ↗

FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation SequencingSemantic proximity Read ↗

Analysis of genome-wide mutation profile and establishment of risk signature for prognosis of bladder cancerSemantic proximity Read ↗

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.